3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Venous Thrombosis
1
Thrombosis
1
Thromboembolism
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Inflammation
1
Immune System Diseases
1
Gastrointestinal Stromal Tumors
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Aspirin
2
sofosbuvir-velpatasvir drug combination
1
palbociclib
1
beta Carotene
1
Vitamin E
1
Vitamin D
1
Rivaroxaban
1
Referral and Consultation
1
Progestins
1
Lysine Acetyltransferase 5
1
Hormone Replacement Therapy
1
Health Information Exchange
1
Geritol
1
Ethanol
1
Estrogens
1
Estrogen Replacement Therapy
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Calcium
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiovascular Diseases
×
Rivaroxaban
×
Gastrointestinal
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled